Die Chorioretinitis centralis serosa und die depressive Störung – eine psychosomatische Perspektive

Zusammenfassung

Die Chorioretinitis centralis serosa wird in ätiologischen Überlegungen immer wieder mit einem unspezifischen Distresskonzept in Zusammenhang gebracht. Die depressive Störung stellt hingegen einen klar benennbaren, spezifischen Stressor dar, der nicht zuletzt in der Kardiologie wie Diabetologie als bedeutender, eigenständiger Risikofaktor bekannt ist. In vorliegendem Fallbericht wird aus psychosomatischer Sicht die klinische Korrelation zwischen einer Chorioretinitis centralis serosa und einer depressiven Störung aufgezeigt, wobei ein lediglich ad hoc naheliegendes sequenziell-reaktives Störungsverständnis demjenigen einer simultanen Verschränkung gegenübergestellt wird, welches nach unserem Ermessen zu bevorzugen wäre.

Abstract

Central serous chorioretinitis serosa is repeatedly brought into aetiological considerations with a rather unspecific concept of distress. Depressive disorder represents a specific stressor, which is known in cardiology or diabetology as a significant risk factor. In the present case report, the clinical correlation between a central serous chorioretinitis and a depressive disorder is shown from a psychosomatic point of view, comparing a sequentially-reactive understanding of the disorder complex with a preferable model of simultaneous entanglement.

Schlüsselwörter

intraokulare Entzündungen - Pathologie - Retina

Key words

intraocular inflammation - pathology - retina

• Literatur

• 1 Spahn C, Wiek J, Burger T et al. Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 2003; 87: 704-708
• 2 Wynn PA. Idiopathic central serous chorioretinopathy–a physical complication of stress?. Occup Med (Lond) 2001; 51: 139-140
• 3 Conrad R, Bodeewes I, Schilling G et al. [Central serous chorioretinopathy and psychological stress]. Ophthalmologe 2000; 97: 527-531
• 4 Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987; 144: 46-50
• 5 Lipowski ZJ, Kiriakos RZ. Psychosomatic aspects of central serous retinopathy. A review and case report. Psychosomatics 1971; 12: 398-401
• 6 Franke GH, Esser J, Stacker KH et al. [“Filtered normality”: psychological causes and sequelae of specific retinal diseases]. Psychother Psychosom Med Psychol 1996; 46: 159-168
• 7 Liew G, Quin G, Gillies M et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013; 41: 201-214
• 8 Nicholson B, Noble J, Forooghian F et al. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013; 58: 103-126
• 9 Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 2011; 22: 166-173
• 10 Gemenetzi M, de Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 2010; 24: 1743-1756
• 11 Gagnier JJ, Kienle G, Altman DG et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014; 67: 46-51
• 12 Schnell K, Herpertz SC. Psychotherapy in psychiatry: the current situation and future directions in Germany. Eur Arch Psychiatry Clin Neurosci 2011; 261 (Suppl. 02) S129-S134
• 13 Wittchen HU, Wunderlich U, Gruschwitz S et al. Strukturiertes klinisches Interview für DSM-IV, Achse I (SKID). Göttingen: Hogrefe; 1997
• 14 APA. Diagnostic and statistic Manual of mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 2000
• 15 DIMDI (Deutsches Institut für Medizinische Dokumentation und Information). ICD-10-GM Version 2013. Köln: DIMDI; 2013
• 16 WHO. Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. 8. Aufl. Bern: Hans Huber; 2011
• 17 Jain AK, Kaines A, Schwartz S. Bilateral central serous chorioretinopathy resolving rapidly with treatment for obstructive sleep apnea. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1037-1039
• 18 Cotticelli L, Borrelli M, DʼAlessio AC et al. Central serous chorioretinopathy and helicobacter pylori. Eur J Ophthalmol 2006; 16: 274-278
• 19 Spalding JM. Central serous chorioretinopathy and HIV. J Am Optom Assoc 1999; 70: 391-398
• 20 Nucci C, Corsi A, Mancino R et al. Central serous chorioretinopathy in patients with psoriasis. Acta Ophthalmol Scand 2004; 82: 105-107
• 21 Schreiber JB, Lakhanpal V, Nasrallah SM. Crohnʼs disease complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment. Dig Dis Sci 1989; 34: 118-122
• 22 Cunningham jr. ET, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996; 103: 2081-2090
• 23 Khairallah M, Kahloun R, Tugal-Tutkun I. Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm 2012; 20: 76-85
• 24 Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 2012; 32 (Suppl. 01) 709
• 25 Haimovici R, Koh S, Gagnon DR et al. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004; 111: 244-249
• 26 Tsai DC, Chen SJ, Huang CC et al. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001–2006: a population-based study. PloS One 2013; 8: e66858
• 27 Tittl MK, Spaide RF, Wong D et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-68
• 28 Chan WM, Lai TY, Tano Y et al. Photodynamic therapy in macular diseases of asian populations: when East meets West. Jpn J Ophthalmol 2006; 50: 161-169
• 29 Venkatesh P, Gadia R, Tewari HK et al. Prehypertension may be common in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1101-1103
• 30 Turkcü FM, Yüksel H, Sahin A et al. Effects of smoking on visual acuity of central serous chorioretinopathy patients. Cutan Ocul Toxicol 2013;
• 31 Ascaso FJ, Cruz N, Del Buey MA et al. An unusual case of cocaine-induced maculopathy. Eur J Ophthalmol 2009; 19: 880-882
• 32 Piskunowicz M, Jaracz M, Lesiewska H et al. Temperament profile in patients with central serous chorioretinopathy: a case-control study. Eur J Ophthalmol 2014; 24: 392-395
• 33 Conrad R, Weber NF, Lehnert M et al. Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics 2007; 48: 489-495
• 34 Sahin A, Bez Y, Kaya MC et al. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Semin Ophthalmol 2014; 29: 73-76
• 35 Fok AC, Chan PP, Lam DS et al. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res 2011; 46: 160-163
• 36 Kaiser HJ, Erb C, Flammer J. Augenheilkunde. In: Adler RH, Herzog W, Joraschky P, et al., Hrsg. Uexküll Psychosomatische Medizin: Theoretische Modelle und klinische Praxis. 7. Aufl. München: Urban & Fischer (Elsevier GmbH); 2010: 1127-1135
• 37 Maier M, Stumpfe S, Feucht N et al. [Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy]. Ophthalmologe 2014; 111: 173-180
• 38 Rouvas AA, Chatziralli IP, Ladas ID et al. The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation?. Eur J Ophthalmol 2013;
• 39 Kitzmann AS, Pulido JS, Diehl NN et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 2008; 115: 169-173
• 40 Bahrke U, Krause A, Walliser U et al. [Retinopathia centralis serosa–stomach ulcer of ophthalmology?]. Psychother Psychosom Med Psychol 2000; 50: 464-469
• 41 Hammen C. Stress and depression. Annu Rev Clin Psychol 2005; 1: 293-319
• 42 Hammen C. Generation of stress in the course of unipolar depression. J Abnorm Psychol 1991; 100: 555-561
• 43 Lin EH, Rutter CM, Katon W et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010; 33: 264-269
• 44 Lippi G, Montagnana M, Favaloro EJ et al. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 2009; 35: 325-336
• 45 Rozanski A, Blumenthal JA, Davidson KW et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637-651
• 46 Huisingh C, McGwin G. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Br J Ophthalmol 2014; 98: 570-571
• 47 Tsai DC, Huang CC, Chen SJ et al. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study. Br J Ophthalmol 2012; 96: 1484-1488
• 48 Tsai DC, Huang CC, Chen SJ et al. Increased risk of erectile dysfunction among males with central serous chorioretinopathy – a retrospective cohort study. Acta Ophthalmol 2013; 91: 666-671
• 49 Kessing LV. Endogenous, reactive and neurotic depression – diagnostic stability and long-term outcome. Psychopathology 2004; 37: 124-130
• 50 Paykel ES. Basic concepts of depression. Dialogues Clin Neurosci 2008; 10: 279-289
• 51 Chung YR, Seo EJ, Lew HM et al. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review. Eye 2013; 27: 1339-1346
• 52 Spahn C, Wiek J, Burger T. [Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy]. Psychother Psychosom Med Psychol 2004; 54: 52-57
• 53 Tewari HK, Gadia R, Kumar D et al. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophthalmol Vis Sci 2006; 47: 3474-3478
• 54 Bernasconi P, Messmer E, Bernasconi A et al. Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability. Graefes Arch Clin Exp Ophthalmol 1998; 236: 571-576
• 55 Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744
• 56 Gräfe K, Zipfel S, Herzog W et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Diagnostica 2004; 50: 171-181